๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON ยท Real-Time Price ยท USD
0.1134
-0.0273 (-19.40%)
At close: Nov 17, 2026, 4:00 PM EST
0.1194
+0.0060 (5.29%)
Pre-market: Nov 18, 2026, 6:53 AM EST

AEON Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-21.87-16.3-27.82-52.84-48.43-36.88
Net Income
-47.62-39.2242.01-384.63-52.56-55.64
Earnings Per Share
-0.98-3.9572.93-4.99-27.25-31.73
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
11.423.010.015.169.755.13
Total Debt
2.7935.7512.960.28131.7986.89
Net Cash (Debt)
8.63-32.74-12.944.88-122.05-81.76
Net Cash Growth
------
Net Cash Per Share
0.18-3.30-22.470.06-63.29-46.63

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--17.31-20.29-47.83-35.58-28.43
Capital Expenditures
--0---0.31-0.17
Free Cash Flow
--17.31-20.29-47.83-35.89-28.6
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.51---